Oncolytics Biotech Inc. (ONC.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
3.4500-0.0500 (-1.43%)
At close: 3:55PM EST
| Previous Close | 3.5000 |
| Open | 3.4600 |
| Bid | 3.4300 x 0 |
| Ask | 3.4500 x 0 |
| Day's Range | 3.3000 - 3.5300 |
| 52 Week Range | 1.3500 - 5.3700 |
| Volume | 100,090 |
| Avg. Volume | 241,391 |
| Market Cap | 151.546M |
| Beta (5Y Monthly) | 1.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9020 |
| Earnings Date | Nov. 11, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.80 |
- CNW Group
Nymi survey reveals the majority of Americans would welcome using a wearable at work, as companies seek technology to plan for safe returns to workplaces
TORONTO, Jan. 13, 2021 /CNW/ --Â Nymi, Inc.
- CNW Group
GAC MOTOR 2020 Review: Contrarian Upswing, Promising Future
GUANGZHOU, China, Dec. 23, 2020 /CNW/ -- In 2020, GAC MOTOR expanded enthusiastically into the international automobiles market.
- CNW Group
Oncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer Symposium
\\- Pelareorep strongly increases CelTIL score, the primary endpoint and a measure of tumor cellularity and inflammation associated with favorable clinical outcomes\\- Pelareorep increased tumor PD-L1 expression 105-fold, thereby making the tumors more amenable to immuno-checkpoint inhibitor treatmentSAN DIEGO and CALGARY, AB, Dec. 9, 2020 /CNW/ -- Oncolytics Biotech® Inc.
© 2021 Verizon Media. All rights reserved.
